Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AAI/CML Expands Sterile Fill-Finish Capabilities | Contract Pharma

AAI/CML Expands Sterile Fill-Finish Capabilities

Adds lyophilization unit doubling the site's capacity

AAIPharma Services Corp./Cambridge Major Laboratories, Inc. (AAI/CML) has expanded sterile fill-finish capabilities and capacity in its Charleston, SC site.
 
AAI/CML has invested in significant upgrades to equipment and staff since acquiring the site in 2001, including a small-scale lyophilizer for cycle development studies conducted by a formulation development team on site. A second line for GMP batches was qualified in 2015 to support sterile manufacturing, more than doubling filling capacity. Recently, a new, mid-scale lyophilization unit has been installed and will be qualified by May, doubling the site’s lyophilization capacity. The unit includes formulation development, fill/finish, packaging and testing for batch sizes up to 400L. Also, a third manufacturing shift has been added, increasing scheduling flexibility.
 
“These upgrades to our manufacturing facility in Charleston support the overall progress of our growth as a company to meet the needs of our customers. We are excited to offer increased sterile manufacturing capacity to the market and added capabilities for specialized areas of drug product development and manufacturing,” stated Ted Dolan, chief operating officer.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters